LIMA (Reuters) – Peru has given ‘exceptional’ approval for the import and use of 1 million COVID-19 vaccines from China’s Sinopharm, two government sources told Reuters on Wednesday as the Andean nation grapples with a new wave of infections.
(Reporting by Marco Aquino; Writing by Adam Jourdan)
